Deutsche Bank Ag\ Zynerba Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$3.23 - $4.3 $646 - $860	-200 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$3.31 - $6.54 $25,351 - $50,089	-7,659 Reduced 97.46%	200 $1,000
Q1 2020 May 14, 2020	SELL	$2.9 - $6.16 $250,609 - $532,328	-86,417 Reduced 91.66%	7,859 $30,000
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $490,975 - $750,029	87,518 Added 1295.03%	94,276 $568,000
Q3 2019 Nov 14, 2019	SELL	$7.56 - $15.44 $74,246 - $151,636	-9,821 Reduced 59.24%	6,758 $49,000
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $89,526 - $256,974	16,579 New	16,579 $223,000
Q1 2019 May 15, 2019	SELL	$3.6 - $6.22 $1.01 Million - $1.74 Million	-279,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.89 - $7.91 $803,116 - $2.2 Million	277,895 Added 17314.33%	279,500 $830,000
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $20,062 - $37,505	-3,589 Reduced 69.1%	1,605 $13,000
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $109,238 - $169,606	-13,689 Reduced 72.49%	5,194 $50,000
Q1 2018 Oct 18, 2019	BUY	$8.49 - $13.46 $23,313 - $36,961	2,746 Added 17.02%	18,883 $163,000
Q1 2018 May 15, 2018	SELL	$8.49 - $13.46 $94,374 - $149,621	-11,116 Reduced 40.79%	16,137 $139,000
Q4 2017 Feb 14, 2018	SELL	$8.69 - $14.59 $387,904 - $651,268	-44,638 Reduced 62.09%	27,253 $340,000
Q3 2017 Nov 14, 2017	BUY	$5.73 - $9.44 $411,935 - $678,651	71,891	71,891 $600,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.